Sign in
Taking peopleNo phase

Study on Theraputic Drug Monitoring and Phamacokinetics of Isavuconazole in Children

Key facts

Who runs it
Shanghai Children's Medical Center
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
200 people, planned
Started
6 Jun 2024
Planned end
30 Jun 2026
Type of study
Interventional
Treatments tested
  • Theraputic drug monitoring
  • Isavuconazole
Record updated
13 December 2024

Who can take part

Age
Up to 18 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Patients who intend to take isavuconazole for the treatment of invasive mycosis
  • Aged 0-18 years, gender unlimited
  • The subject and his/her guardian are willing to comply with the procedures and operations specified in the study protocol
  • The guardian of the subject and the subject of independent informed age are willing and able to provide written informed consent to participate in the study

Who cannot take part

  • The subject is known to be allergic to any azole antifungal therapy or other ingredients contained in the study drug
  • The researcher believes that the condition of the child may interfere with study participation or other inappropriate conditions

This trial is currently available in China.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this clinical trial is to learn the plasma concentration of isavuconazole in pediatric patients. It will also learn about the relationship of isavuconazole plasma concentrations to efficacy and safety in pediatric patients. The main questions it aims to answer are:

Read full original descriptionShow less

What is the plasma concentration after using isavuconazole in pediatric patients? What is the effective range of plasma concentration of isavuconazole in pediatric patients? What is the safe range of plasma concentration of isavuconazole in pediatric patients? Researchers will measure the plasma concentration of isavuconazole to see whether it is appropriate.

Participants will:

Take drug isavuconazole as prescribed by the doctor;

1mL of blood is drawn 30min before the next dose.

The group in the trial

  • Isavuconazole groupOther group

    Theraputic drug monitoring

    Treatment: Theraputic drug monitoring and Isavuconazole

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
13 December 2024